Open Government Portal
The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination …
The purpose of this Notice of Amendment is to notify about the additions of fostamatinib, givosiran, lemborexant, luspatercept, ozanimod, trientine, …
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health …
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health …
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health …
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.